Search

Author/Creator Webb, David J

1. A novel role for myeloid endothelin-B receptors in hypertension. (17th January 2019)

Authors:
Czopek, Alicja; Moorhouse, Rebecca; Guyonnet, Léa; Farrah, Tariq; Lenoir, Olivia; Owen, Elizabeth; van Bragt, Job; Costello, Hannah M; Menolascina, Filippo; Baudrie, Véronique; Webb, David J; Kluth, David C; Bailey, Matthew A; Tharaux, Pierre-Louis; Dhaun, Neeraj
Journal:
European heart journal
Issue:
Volume 40:Number 9(2019)
Page Start:
768
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Issue 10361 (22nd October 2022)

Authors:
Mackenzie, Isla S; Rogers, Amy; Poulter, Neil R; Williams, Bryan; Brown, Morris J; Webb, David J; Ford, Ian; Rorie, David A; Guthrie, Greg; Grieve, J W Kerr; Pigazzani, Filippo; Rothwell, Peter M; Young, Robin; McConnachie, Alex; Struthers, Allan D; Lang, Chim C; MacDonald, Thomas M
Journal:
Lancet
Issue:
Volume 400:Issue 10361(2022)
Page Start:
1417
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension. Issue 8 (7th August 2015)

Authors:
Brown, Morris J; Williams, Bryan; MacDonald, Thomas M; Caulfield, Mark; Cruickshank, J Kennedy; McInnes, Gordon; Sever, Peter; Webb, David J; Salsbury, Jackie; Morant, Steve; Ford, Ian
Journal:
BMJ open
Issue:
Volume 5:Issue 8(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial. Issue 2 (February 2016)

Authors:
Brown, Morris J; Williams, Bryan; Morant, Steve V; Webb, David J; Caulfield, Mark J; Cruickshank, J Kennedy; Ford, Ian; McInnes, Gordon; Sever, Peter; Salsbury, Jackie; Mackenzie, Isla S; Padmanabhan, Sandosh; MacDonald, Thomas M
Journal:
Lancet
Issue:
Volume 4:Issue 2(2016)
Page Start:
136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies. Issue 6 (June 2018)

Authors:
Williams, Bryan; MacDonald, Thomas M; Morant, Steve V; Webb, David J; Sever, Peter; McInnes, Gordon T; Ford, Ian; Cruickshank, J Kennedy; Caulfield, Mark J; Padmanabhan, Sandosh; Mackenzie, Isla S; Salsbury, Jackie; Brown, Morris J
Journal:
Lancet
Issue:
Volume 6:Issue 6(2018)
Page Start:
464
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗